|
RGLS Regulus Therapeutics Inc 1505512 |
| Balance Sheet |
|
Current Assets
|
91,687,000 |
|
Assets
|
93,763,000 |
|
Current Liabilities
|
6,482,000 |
|
Liabilities
|
6,958,000 |
|
Equity
|
86,805,000 |
|
Shares Out
|
65,466,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-29,828,000 |
|
Investing Cash Flow
|
-59,983,000 |
| Market Analysis |
Market Cap
|
104,326,460 |
|
Price
|
1.24 |
|
BVPS
|
1.33 |
|
PB
|
0.94 |
|
EPS
|
-1.26 |
|
PS
|
1.61 |
|
FCF
|
-89,811,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGLS documents filed with the SEC.
RGLS Filings
Clear
